Introducing BICO, as CELLINK evolves into bio convergence

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

As 3dpbm anticipated in July, CELLINK AB is officially transitioning to BICO, concentrating on the intersection of biology and technology  Since its founding in 2016, BICO has built one of the world’s most expansive portfolios of life science products that spans bioprinting, diagnostics, lab automation and multi-omics among other key verticals, solidifying itself as the market leader in bio convergence; a rapidly growing industry. This shift will enable BICO and its 11 subsidiaries to even more rapidly, and more customer-obsessed, innovate through the Group’s shared bio convergence agenda which entails investments in bioengineering, technology development, product design and UX as well as sales and marketing.

Introducing BICO
Erik Gatenholm, CEO and President BICO

In the last five years, BICO has seen exponential growth including expansion to 900+ employees over 11 subsidiaries, as well as sales and distribution in 65+ countries in over 2,000 laboratories. The launch of BICO draws a clear path for the future of the company by developing the future of health among three key business areas: Bioprinting, Biosciences and Bioautomation. By combining these different technologies, BICO will enable its customers and researchers to improve people’s health and lives for the better. CELLINK Bioprinting will continue to prosper under the BICO umbrella as the strong industry leader in 3D bioprinting and with its broad portfolio of consumables e.g., bioinks and tissue engineering products.

“In five years, we have built a world-leading group that offers something truly unique – a bio convergence revolution”, said Erik Gatenholm, CEO and President BICO. “As the company has continued to grow, we saw limitations to make a radical change in the industry at our customers’ laboratories with just one product. We realized that our customers needed more and better technologies, products, solutions, and workflows for the most optimal outcome where we together can create the most change. I am proud to introduce BICO to the world and look forward to continuing to push the boundaries of science to create the future of health.”

The company will be focused on five central areas, including the enabling of safer and accessible organ transplants, utilization of cultivated tissue from human cells to eliminate unnecessary animal testing, faster development of more affordable medicines, more personalized medicines, as well as faster and less expensive diagnostics to fight infectious diseases.

“Today’s healthcare challenges require complex and multifaceted solutions. The bio convergence principle embodies this novel approach and will enable researchers to uncover the answers to shape the future of health”, said Dr. Robert Langer, professor at the Massachusetts Institute of Technology, co-founder of Moderna and member of the BICO Scientific Advisory Board. “I’m excited to continue to work with BICO and am eager to see the progress they make.”

The subsidiaries that are a part of BICO will keep their names and operate as individual companies. The company’s ticker has been updated from CLNK to BICO. There have been no additional changes to the company’s financial instruments.

Research 2022
Polymer AM Market Opportunities and Trends

741 unique polymer AM companies individually surveyed and studied. Core polymer AM market generated $4.6 billion...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based 3dpbm. Today the company publishes the leading news and insights websites 3D Printing Media Network and Replicatore, as well as 3D Printing Business Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*